Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Takakazu Yokokura

Takakazu Yokokura

Okinawa Institute Science and Technology Graduate University, Japan

Title: Defining Conserved Spinal Muscular Atrophy Gene Networks that is are Involved in Neuromuscular system using Drosophila SMA model

Biography

Biography: Takakazu Yokokura

Abstract

Spinal Muscular Atrophy (SMA) is a devastating inherited disorder characterized by progressive loss of motor activity, failure of neuromuscular synapses and muscle weakness. Genetic cause of SMA is mutation of Survival Motor Neuron 1 (SMN1) gene, while genetic factor determining severity of symptom is copy number of Survival Motor Neuron 2 (SMN2) gene, which only generate small amount of SMN protein due to skipping a functionally important exon at high frequency. As SMN has been considered as a key factor to regulate neuronal cell function cell autonomously, up-regulating SMN protein in spinal cord motor neurons at pre-symptomatic stages is the most advanced therapeutic approaches to prevent, or, at least, delay irreversible loss of motor neurons. However, the fact that SMA patients exhibit muscle weakness and experience fatigue suggests that it is little known underlying mechanism how low SMN levels affect to trans-synaptic biology at the neuromuscular junction (NMJ). Trans-synaptic structure and signaling at the NMJ play important roles for establishment and maintenance of neuromuscular connectivity and functions. As pathological observation in post-mortal NMJ specimen or rodent SMA models exhibited abnormality in neuromuscular connectivity, utilizing Drosophila NMJ, which is well characterize its structure and molecular mechanism, allow us to understand how low levels of SMN perturbs structure and molecular mechanism at the NMJ in depth. Severe SMN mutants exhibited two phenotypes in motor unit known as SMA pathology, loss of motor axon and abnormality at the NMJ. Modulation of trans-synaptic two canonical signaling pathways, BMP and FGF signaling, that have shown genetic interaction to SMN, can rescue the SMN defects. In addition, each pathway seems to modulate distinct aspect of SMA motor unit pathology.